Picture [iito] Life Science Business Portals Media Data 2022 650x100px

Organisation › Details

EnBiotix Inc.

https://www.enbiotix.com

Enbiotix is a privately-held, rare disease company with an initial focus on chronic respiratory diseases. EnBiotix is headquartered in Boston, Massachussets, USA with its affiliate, EnBiotix, GmbH based in Leipzig, Germany. *

	Start	2016-11-03 existent
	Group	Spexis (Group)
	Industry	antibiotic
	Industry 2	drug development
	Person	Wager, Jeffrey D. (EnBiotix 201611 CEO)

	Region	Cambridge, MA
	Country	United States (USA)
	Street	77 Massachusetts Avenue MIT
	City	02139 Cambridge, MA
		Address record changed: 2021-11-06

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½: Polyphor Ltd.. (9/1/21). "Press Release: Polyphor and EnBiotix Announce Signing of Merger Agreement and Sale of Inhaled Murepavadin to EnBiotix". Allschwil.

		Record changed: 2021-11-06

Picture [iito] Made Without Love 650x100px

More documents for Spexis (Group)

[1] Polyphor Ltd.. (29/10/21). "Press Release: Polyphor Shareholders Approve All Resolutions for the Planned Merger with EnBiotix at the Extraordinary General Meeting". Allschwil....
[2] Polyphor Ltd.. (9/10/21). "Press Release: Polyphor and EnBiotix Announce Closing of Purchase Agreement of Inhaled Murepavadin by EnBiotix". Allschwil....
[3] Polyphor Ltd.. (9/1/21). "Press Release: Polyphor and EnBiotix Announce Signing of Merger Agreement and Sale of Inhaled Murepavadin to EnBiotix". Allschwil....
[4] Polyphor Ltd.. (7/16/21). "Press Release: Polyphor Provides Update on the Future of the FORTRESS Study of Balixafortide and Announces Initial Restructuring Steps". Allschwil....
[5] Polyphor Ltd.. (6/28/21). "Press Release: Polyphor Provides Update on the Phase III FORTRESS Study of Balixafortide in Patients with Advanced HER2 Negative Breast cancer". Allschwil....
[6] Polyphor Ltd.. (10/14/20). "Press Release: Polyphor Receives CARB-X Award of up to USD 18.44 Million to Support Development of New Antibiotic Program". Allschwil....
[7] Polyphor Ltd.. (7/28/20). "Press Release: Polyphor Strengthens Financial Flexibility with CHF 19.3 million Equity-linked Financing". Allschwil....
[8] Polyphor Ltd.. (1/23/20). "Press Release: Polyphor Appoints Gökhan Batur as Chief Executive Officer". Allschwil....
[9] Polyphor Ltd.. (6/27/19). "Press Release: Polyphor Appoints Frank Weber as New Chief Medical and Development Officer". Allschwil....
[10] Polyphor Ltd.. (5/29/19). "Press Release: Polyphor and the University of Zurich Receive an Award from Innosuisse to Accelerate the Development of a New Class of Antibiotics Inhibiting the LPS Transport Pathway". Allschwil....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]